- Home
- ABEO vs MCR Comparison
ABEO vs MCR Comparison
Compare ABEO & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | MCR |
|---|---|---|
| Founded | 1974 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 246.2M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | MCR |
|---|---|---|
| Price | $5.28 | $5.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 960.7K | 95.8K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.52% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ 1.01 | 0.38 |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | ★ $5.33 | $15.75 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $5.84 |
| 52 Week High | $7.54 | $6.57 |
Technical Indicators
Market Signals| Indicator | ABEO | MCR |
|---|---|---|
| Relative Strength Index (RSI) | 54.67 | 39.81 |
| Support Level | $5.24 | $5.84 |
| Resistance Level | $5.30 | $6.34 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 50.54 | 15.63 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.